Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gottehrer, A.
Right arrow Articles by Sahn, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottehrer, A.
Right arrow Articles by Sahn, S. A.

Chest, Vol 100, 1003-1006, Copyright © 1991 by American College of Chest Physicians

ARTICLES

Pleural fluid analysis in malignant mesothelioma. Prognostic implications

A Gottehrer, DA Taryle, CE Reed and SA Sahn
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston 29705.

Pleural fluid characteristics of 26 patients diagnosed with malignant mesothelioma over an 18-year period were reviewed and compared with those of patients with effusions due to other malignancies. Survival from time of initial thoracentesis was directly correlated with pleural pH and decreased pleural fluid/serum glucose ratios but was not related to protein or LDH concentration. Decreased pleural fluid pH was statistically related to a decreased pleural fluid/serum glucose ratio. Patients with low pH (less than 7.30) pleural effusions had statistically decreased mean survival and decreased mean pleural fluid/serum glucose ratios compared with patients with normal pH (greater than or equal to 7.30). Patients with malignant mesothelioma pleural effusions had statistically decreased mean pleural fluid pH compared with patients with other malignant pleural effusions. Decreased levels of pleural fluid pH and pleural fluid/serum glucose ratios have negative prognostic significance and probably correlate with the degree of tumor bulk affecting the pleural surface.


This article has been cited by other articles:


Home page
 ChestHome page
J. E. Heffner, J. N. Heffner, and L. K. Brown
Multilevel and Continuous Pleural Fluid pH Likelihood Ratios for Evaluating Malignant Pleural Effusions
Chest, June 1, 2003; 123(6): 1887 - 1894.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Hughes, P. Calvert, A. Azzabi, R. Plummer, R. Johnson, J. Rusthoven, M. Griffin, K. Fishwick, A. V Boddy, M. Verrill, et al.
Phase I Clinical and Pharmacokinetic Study of Pemetrexed and Carboplatin in Patients With Malignant Pleural Mesothelioma
J. Clin. Oncol., August 15, 2002; 20(16): 3533 - 3544.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. E. Heffner, P. J. Nietert, and C. Barbieri
Pleural Fluid pH as a Predictor of Survival for Patients With Malignant Pleural Effusions*
Chest, January 1, 2000; 117(1): 79 - 86.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. C. Grondin and D. J. Sugarbaker
Pleuropneumonectomy in the Treatment of Malignant Pleural Mesothelioma*
Chest, December 1, 1999; 116(suppl_3): 450S - 454S.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American College of Chest Physicians.